SML0938
Dofequidar fumarate
≥98% (HPLC)
别名:
4-(Diphenylacetyl)-a-[(5-quinolinyloxy)methyl]-1-Piperazineethanol (E)-2-butenedioate fumarate (1:1.5), MS-209 fumarate
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
Assay:
≥98% (HPLC)
Form:
powder
Storage condition:
desiccated
assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: 20 mg/mL, clear
storage temp.
−20°C
InChI
1S/2C30H31N3O3.3C4H4O4/c2*34-25(22-36-28-15-7-14-27-26(28)13-8-16-31-27)21-32-17-19-33(20-18-32)30(35)29(23-9-3-1-4-10-23)24-11-5-2-6-12-24;3*5-3(6)1-2-4(7)8/h2*1-16,25,29,34H,17-22H2;3*1-2H,(H,5,6)(H,7,8)/b;;3*2-1+
InChI key
ZGMJYTYLTJFNCS-VQYXCCSOSA-N
Biochem/physiol Actions
Dofequidar fumarate is a potent inhibitor of MDR-1.
Dofequidar fumarate is a potent inhibitor of MDR-1. The compound Dofequidar fumarate sensitizes tumor cells to cytotoxic drugs.
Features and Benefits
This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
商品
Discover Bioactive Small Molecules for ADME/Tox
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| SML0938-25MG | 04061833224373 |
| SML0938-5MG | 04061833224380 |